In order to validate our potential biomarkers, we utilized an independent cohort containing 36 meningioma tumor samples, and found that amphiregulin and Caspase 3 are significantly increased in meningioma tumor tissues, while VEGF-D is relatively lower in comparison to the control NWM tissue samples (Figure 2). Here, VEGFD is linked to meningioma.